The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Somatuline Autogel 120mg, solution for injection in a pre-filled syringe



Originalis B.V.PPA2306/026/002

Main Information

Trade NameSomatuline Autogel 120mg, solution for injection in a pre-filled syringe
Active SubstancesLanreotide
Dosage FormSolution for injection in pre-filled syringe
Licence HolderOriginalis B.V.
Licence NumberPPA2306/026/002

Group Information

ATC CodeH01CB Somatostatin and analogues
H01CB03 lanreotide

Status

License statusAuthorised
Licence Issued10/02/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back